[1] WANG Y,YANG Q,LI S,et al. Imaging features of combined hepatocellular and cholangiocarcinoma compared with those of hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in a Chinese population[J]. Clin Radiol,2019,74(5):407.
|
[2] WANG H,CONG WM. Progress in clinical pathology of new subtypes of bicotypic hepatocellular carcinoma[J]. Chin J Clin Oncol,2017,44(12):616-619.(in Chinese)王瀚,丛文铭.双表型肝细胞癌新亚型的临床病理学研究进展[J].中国肿瘤临床,2017,44(12):616-619.
|
[3] LU XY,XI T,LAU WY,et al. Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior[J]. Ann Surg Oncol,2011,18(8):2210-2217.
|
[4] LIU M,SHI Y,ZHANG W,et al. Expression of CK19 andβ-catenin in primary hepatocellular carcinoma and its clinical significance[J]. J Xinjiang Med Univ,2016,39(8):1004-1008,1011.(in Chinese)刘铭,师艺,张巍,等.CK19及β-catenin在原发性肝细胞肝癌中的表达及其临床意义[J].新疆医科大学学报,2016,39(8):1004-1008,1011.
|
[5] WAKIZAKA K,YOKOO H,KAMIYAMA T,et al. Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers[J]. J Gastroenterol Hepatol,2019,34(6):1074-1080.
|
[6] LI AM,ZHU YZ. Advances in imaging diagnosis of primary intrahepatic cholangiocarcinoma[J]. Milit Med J Southeast China,2019,21(5):517-520.(in Chinese)李艾梅,朱友志.原发肝内胆管细胞癌的影像学诊断进展[J].东南国防医药,2019,21(5):517-520.
|